Press Releases

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

Awarded annually since 1955, the Sloan Research Fellowships honor exceptional U.S. and Canadian researchers whose creativity, leadership, innovation, and research accomplishments make them stand out as the next generation of leaders.

On World Cancer Day, MSK Launches Public-Service Announcement ‘Late,’ Emphasizing the Urgency and Power of Routine Cancer Screenings

Cycle for Survival, the official rare cancer fundraising event of Memorial Sloan Kettering Cancer Center (MSK), will begin its 2024 signature team stationary-cycling events. As the founding partner of Cycle for Survival, Equinox will have its instructors leading high-energy rides across the country. 100% of the funds raised go directly to rare cancer research at MSK.

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

The Fred’s Team community reached a new milestone during the 2023 season by raising $8 million. 100% of the funds raised will go directly to cancer research at Memorial Sloan Kettering Cancer Center.

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce Selwyn M. Vickers, MD, President and CEO of MSK, is among 30 international scientific leaders elected today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy class of 2024.

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

Memorial Sloan Kettering Cancer Center (MSK) today announced the largest single donation in its nearly 150-year history, a $400 million gift from Kenneth C. Griffin, Founder and Chief Executive Officer of Citadel and Founder of Griffin Catalyst, and David Geffen, Founder of The David Geffen Foundation. It will serve as the cornerstone of MSK’s foundation for the future and will be instrumental in extending the power and potential of cancer care and treatment to people across New York and around the world as MSK continues to advance cutting-edge research and new cancer treatments.

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.